Literature DB >> 22837208

LGP2 downregulates interferon production during infection with seasonal human influenza A viruses that activate interferon regulatory factor 3.

Meghana Malur1, Michael Gale, Robert M Krug.   

Abstract

LGP2, a member of the RIG-I-like receptor family, lacks the amino-terminal caspase activation recruitment domains (CARDs) required for initiating the activation of interferon regulatory factor 3 (IRF3) and interferon (IFN) transcription. The role of LGP2 in virus infection is controversial, and the only LGP2 experiments previously carried out with mammalian influenza A viruses employed an attenuated, mouse-adapted H1N1 A/PR/8/34 (PR8) virus that does not encode the NS1 protein. Here we determine whether LGP2 has a role during infection with wild-type, nonattenuated influenza A viruses that have circulated in the human population, specifically two types of seasonal influenza A viruses: (i) H3N2 and H1N1 viruses that activate IRF3 and IFN transcription and (ii) recent H1N1 viruses that block these two activations. In human cells infected with an H3N2 virus that activates IRF3, overexpression of LGP2 or its repressor domain decreased STAT1 activation and IFN-β transcription approximately 10-fold. Overexpression of LGP2 also caused a 10-fold decrease of STAT1 activation during infection with other seasonal influenza A viruses that activate IRF3. Using LGP2(+/+) and LGP2(-/-) mouse cells, we show that endogenous LGP2 decreased IFN production during H3N2 virus infection 3- to 4-fold. In contrast, in both mouse and human cells infected with H1N1 viruses that do not activate IRF3, LGP2 had no detectable role. These results demonstrate that LGP2 downregulates IFN production during infection by seasonal influenza A viruses that activate IRF3 and IFN transcription. It is intriguing that LGP2, a host protein induced during influenza A virus infection, downregulates the host antiviral IFN response.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22837208      PMCID: PMC3457329          DOI: 10.1128/JVI.00510-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein.

Authors:  J Talon; C M Horvath; R Polley; C F Basler; T Muster; P Palese; A García-Sastre
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 2.  Viruses and interferon: a fight for supremacy.

Authors:  Michael G Katze; Yupeng He; Michael Gale
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

3.  Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity.

Authors:  Mitsutoshi Yoneyama; Mika Kikuchi; Kanae Matsumoto; Tadaatsu Imaizumi; Makoto Miyagishi; Kazunari Taira; Eileen Foy; Yueh-Ming Loo; Michael Gale; Shizuo Akira; Shin Yonehara; Atsushi Kato; Takashi Fujita
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

4.  VISA is an adapter protein required for virus-triggered IFN-beta signaling.

Authors:  Liang-Guo Xu; Yan-Yi Wang; Ke-Jun Han; Lian-Yun Li; Zhonghe Zhai; Hong-Bing Shu
Journal:  Mol Cell       Date:  2005-09-16       Impact factor: 17.970

5.  Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3.

Authors:  Rashu B Seth; Lijun Sun; Chee-Kwee Ea; Zhijian J Chen
Journal:  Cell       Date:  2005-09-09       Impact factor: 41.582

6.  Influenza A virus strains that circulate in humans differ in the ability of their NS1 proteins to block the activation of IRF3 and interferon-β transcription.

Authors:  Rei-Lin Kuo; Chen Zhao; Meghana Malur; Robert M Krug
Journal:  Virology       Date:  2010-10-08       Impact factor: 3.616

7.  LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses.

Authors:  Takashi Satoh; Hiroki Kato; Yutaro Kumagai; Mitsutoshi Yoneyama; Shintaro Sato; Kazufumi Matsushita; Tohru Tsujimura; Takashi Fujita; Shizuo Akira; Osamu Takeuchi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-08       Impact factor: 11.205

8.  Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems.

Authors:  A García-Sastre; A Egorov; D Matassov; S Brandt; D E Levy; J E Durbin; P Palese; T Muster
Journal:  Virology       Date:  1998-12-20       Impact factor: 3.616

9.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses.

Authors:  Mitsutoshi Yoneyama; Mika Kikuchi; Takashi Natsukawa; Noriaki Shinobu; Tadaatsu Imaizumi; Makoto Miyagishi; Kazunari Taira; Shizuo Akira; Takashi Fujita
Journal:  Nat Immunol       Date:  2004-06-20       Impact factor: 25.606

10.  Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs.

Authors:  M E Nemeroff; S M Barabino; Y Li; W Keller; R M Krug
Journal:  Mol Cell       Date:  1998-06       Impact factor: 17.970

View more
  18 in total

1.  RIG-I-dependent antiviral immunity is effective against an RNA virus encoding a potent suppressor of RNAi.

Authors:  Xiaoxu Fan; Shuwei Dong; Yang Li; Shou-wei Ding; Ming Wang
Journal:  Biochem Biophys Res Commun       Date:  2015-04-03       Impact factor: 3.575

Review 2.  Functions of the influenza A virus NS1 protein in antiviral defense.

Authors:  Robert M Krug
Journal:  Curr Opin Virol       Date:  2015-01-29       Impact factor: 7.090

Review 3.  Activation and pathogenic manipulation of the sensors of the innate immune system.

Authors:  Charlotte Odendall; Jonathan C Kagan
Journal:  Microbes Infect       Date:  2017-01-14       Impact factor: 2.700

Review 4.  Negative regulators of the RIG-I-like receptor signaling pathway.

Authors:  Kendra M Quicke; Michael S Diamond; Mehul S Suthar
Journal:  Eur J Immunol       Date:  2017-04       Impact factor: 5.532

5.  RNA sensor LGP2 inhibits TRAF ubiquitin ligase to negatively regulate innate immune signaling.

Authors:  Jean-Patrick Parisien; Jessica J Lenoir; Roli Mandhana; Kenny R Rodriguez; Kenin Qian; Annie M Bruns; Curt M Horvath
Journal:  EMBO Rep       Date:  2018-04-16       Impact factor: 8.807

6.  Immune regulator LGP2 targets Ubc13/UBE2N to mediate widespread interference with K63 polyubiquitination and NF-κB activation.

Authors:  Jessica J Lenoir; Jean-Patrick Parisien; Curt M Horvath
Journal:  Cell Rep       Date:  2021-12-28       Impact factor: 9.423

7.  RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation.

Authors:  Ryan C Widau; Akash D Parekh; Mark C Ranck; Daniel W Golden; Kiran A Kumar; Ravi F Sood; Sean P Pitroda; Zhengkai Liao; Xiaona Huang; Thomas E Darga; David Xu; Lei Huang; Jorge Andrade; Bernard Roizman; Ralph R Weichselbaum; Nikolai N Khodarev
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

Review 8.  Antiviral RNA recognition and assembly by RLR family innate immune sensors.

Authors:  Annie M Bruns; Curt M Horvath
Journal:  Cytokine Growth Factor Rev       Date:  2014-07-15       Impact factor: 7.638

Review 9.  RIG-I in RNA virus recognition.

Authors:  Alison M Kell; Michael Gale
Journal:  Virology       Date:  2015-03-05       Impact factor: 3.616

Review 10.  The laboratory of genetics and physiology 2: emerging insights into the controversial functions of this RIG-I-like receptor.

Authors:  Zixiang Zhu; Xiangle Zhang; Guoqing Wang; Haixue Zheng
Journal:  Biomed Res Int       Date:  2014-01-16       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.